Literature DB >> 26151334

Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features.

Fiorenza Gianì1, Veronica Vella1, Maria Luisa Nicolosi1, Alessandra Fierabracci1, Sonia Lotta1, Roberta Malaguarnera1, Antonino Belfiore1, Riccardo Vigneri1, Francesco Frasca1.   

Abstract

CONTEXT: Cancer stem cells from several human malignancies, including poorly differentiated thyroid carcinoma and thyroid cancer cell lines, have been cultured in vitro as sphere-forming cells. These thyroid cancer stem cells were proven to be able to reproduce the original tumor in a xenograft orthotopic model.
OBJECTIVES: The objective of the study was to characterize papillary thyroid carcinoma (PTC) spheres from well-differentiated thyroid cancer and normal thyroid (NT) spheres obtained from the contralateral thyroid tissue of the same patient.
DESIGN: Thyrospheres from PTCs and NTs were isolated. MAIN OUTCOME MEASURES: Gene expression analysis by real-time PCR, immunofluorescence studies, and fluorescence-activated cell sorter analysis in thyrospheres from PTCs and NTs have been evaluated.
CONCLUSIONS: Compared with NT spheres, PTC spheres are larger, more irregular, and more clonogenic and have a higher rate of symmetric division. Moreover, PTC spheres express higher levels of stem cell markers and lower levels of thyroid-specific genes compared with NT spheres. Under appropriate conditions, NT spheres differentiated into thyrocytes, whereas PTC spheres did not, displaying a defect in the differentiation potential. Immunofluorescence experiments indicated that, in NT spheres, progenitor cells are mainly present in the sphere core, and the sphere periphery contains thyroid precursor cells already committed to differentiation. PTC spheres are not polarized like NT spheres. Unlike cells differentiated from NT spheres, TSH did not significantly stimulate cAMP production in cells differentiated from PTC spheres. A microarray analysis performed in paired samples (NT and PTC spheres from the same patient) indicated that NT and PTC spheres display a gene expression pattern typical of stem/progenitor cells; however, compared with NT spheres, PTC spheres display a unique gene expression pattern that might be involved in PTC progression.

Entities:  

Mesh:

Year:  2015        PMID: 26151334     DOI: 10.1210/JC.2014-4163

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

2.  Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.

Authors:  Veronica Vella; Roberta Malaguarnera; Maria Luisa Nicolosi; Chiara Palladino; Cristina Spoleti; Michele Massimino; Paolo Vigneri; Michele Purrello; Marco Ragusa; Andrea Morrione; Antonino Belfiore
Journal:  Oncotarget       Date:  2017-06-27

Review 3.  Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Authors:  Roberta Malaguarnera; Veronica Vella; Maria Luisa Nicolosi; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

Review 4.  Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.

Authors:  Domenico Ciavardelli; Maria Bellomo; Ada Consalvo; Caterina Crescimanno; Veronica Vella
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

5.  Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells.

Authors:  Paola Caria; Rita Pillai; Tinuccia Dettori; Daniela Virginia Frau; Patrizia Zavattari; Gabriele Riva; Gabriele Romano; Fabiana Pani; Angela Bentivegna; Roberto Giovannoni; Fabio Pagni; Valeria Sogos; Roberta Vanni
Journal:  J Cancer       Date:  2017-06-03       Impact factor: 4.207

Review 6.  PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

Authors:  Veronica Vella; Maria Luisa Nicolosi; Stefania Giuliano; Maria Bellomo; Antonino Belfiore; Roberta Malaguarnera
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-22       Impact factor: 5.555

Review 7.  The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.

Authors:  Veronica Vella; Roberta Malaguarnera
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

Review 8.  Cancer Stem Cells in the Thyroid.

Authors:  Yuji Nagayama; Mika Shimamura; Norisato Mitsutake
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-29       Impact factor: 5.555

Review 9.  Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.

Authors:  Veronica Veschi; Francesco Verona; Melania Lo Iacono; Caterina D'Accardo; Gaetana Porcelli; Alice Turdo; Miriam Gaggianesi; Stefano Forte; Dario Giuffrida; Lorenzo Memeo; Matilde Todaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

Review 10.  Insulin Receptor Isoforms in Cancer.

Authors:  Veronica Vella; Agostino Milluzzo; Nunzio Massimo Scalisi; Paolo Vigneri; Laura Sciacca
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.